EMEA-001965-PIP01-16

Key facts

Invented name
  • Striverdi
  • Respimat
Active substance
Olodaterol (hydrochloride)
Therapeutic area
Pneumology-allergology
Decision number
P/0112/2017
PIP number
EMEA-001965-PIP01-16
Pharmaceutical form(s)
Inhalation solution
Condition(s) / indication(s)
Treatment of cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Germany
E-mail: paediatrics@boehringer-ingelheim.com
Tel.: +49 6132778271
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating